Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune‐Checkpoint Inhibitors DOI Open Access

Quan Gao,

Hao Wu, Zhengjun Li

и другие.

Phytotherapy Research, Год журнала: 2025, Номер unknown

Опубликована: Март 23, 2025

ABSTRACT Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, immune checkpoint inhibitors (ICIs), has emerged as crucial treatment strategy for lung patients, following surgical intervention, radiotherapy, chemotherapy, targeted drug therapies. However, therapeutic limitations are caused owing to their low response undesirable side effects such immune‐related pneumonitis. Therefore, developing new strategies improve efficacy ICIs while minimizing adverse events will be immunotherapy. The tumor microenvironment plays significant role in success immunosuppressive characteristics major obstacles poor immunotherapeutic effect. Phytochemicals, naturally occurring compounds plants, have shown promise enhancing immunotherapy by remodeling microenvironment, offering potential increase ICIs. this review summarizes associated mechanisms phytochemicals cancer. Additionally, focus on synergistic combining ICIs, aiming anticancer reduce effects, which may hopefully offer novel overcome current

Язык: Английский

Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy DOI

Fahad Alsaikhan

Environmental Research, Год журнала: 2023, Номер 237, С. 116951 - 116951

Опубликована: Авг. 24, 2023

Язык: Английский

Процитировано

12

Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer DOI Open Access
Blanca Estela García‐Pérez, Christian Pérez-Torres, Shantal Lizbeth Baltierra‐Uribe

и другие.

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(19), С. 15016 - 15016

Опубликована: Окт. 9, 2023

Autophagy is a catabolic process that essential to the maintenance of homeostasis through cellular recycling damaged organelles or misfolded proteins, which sustains energy balance. Additionally, autophagy plays dual role in modulating development and progression cancer inducing survival strategy tumoral cells. Programmed cell death-ligand 1 (PD-L1) modulates immune response responsible for maintaining self-tolerance. Because tumor cells exploit PD-L1-PD-1 interaction subvert response, immunotherapy has been developed based on use PD-L1-blocking antibodies. Recent evidence suggested bidirectional regulation between PD-L1 molecule expression Moreover, research into intrinsic properties highlighted new functions are advantageous The relationship complex still not fully understood; its effects can be context-dependent might differ This review refines our understanding non-immune potential influence autophagy, how these could allow cells, what this means efficacy anti-PD-L1 therapeutic strategies.

Язык: Английский

Процитировано

10

Lactylation: The Metabolic Accomplice Shaping Cancer's Response to Radiotherapy and Immunotherapy DOI
Danqing Yu, Qingping Zhong, Yanlin Wang

и другие.

Ageing Research Reviews, Год журнала: 2025, Номер unknown, С. 102670 - 102670

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells DOI

Zebo Jiang,

Qiang He,

Liping Kang

и другие.

Chemical Biology & Drug Design, Год журнала: 2025, Номер 105(2)

Опубликована: Фев. 1, 2025

ABSTRACT Globally, non‐small cell lung cancer (NSCLC) is the primary cause of cancer‐related deaths. Rutecarpine (RUT), a quinazolinocarboline alkaloid that naturally occurring and present in Chinese medicinal herbs, has been shown to have anticancer properties several lines. However, specific antitumor mechanisms RUT NSCLC remain unclear. This study demonstrates induces apoptosis significantly reduces viability effect achieved by stimulating intracellular ROS production, leading mitochondrial dysfunction. The decreased observed with treatment attributed elimination through suppression N‐acetylcysteine (NAC). Furthermore, therapy elevated production CXCL10 CCL5 lines markedly activated STING pathway cells. Mechanistically, substantially levels PD‐L1 protein Notably, vivo experiments demonstrated inhibits mouse tumor growth mice, exhibiting anti‐tumor activity elevating CD8 + T These findings strongly support as promising anti‐cancer drug for NSCLC.

Язык: Английский

Процитировано

0

Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune‐Checkpoint Inhibitors DOI Open Access

Quan Gao,

Hao Wu, Zhengjun Li

и другие.

Phytotherapy Research, Год журнала: 2025, Номер unknown

Опубликована: Март 23, 2025

ABSTRACT Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, immune checkpoint inhibitors (ICIs), has emerged as crucial treatment strategy for lung patients, following surgical intervention, radiotherapy, chemotherapy, targeted drug therapies. However, therapeutic limitations are caused owing to their low response undesirable side effects such immune‐related pneumonitis. Therefore, developing new strategies improve efficacy ICIs while minimizing adverse events will be immunotherapy. The tumor microenvironment plays significant role in success immunosuppressive characteristics major obstacles poor immunotherapeutic effect. Phytochemicals, naturally occurring compounds plants, have shown promise enhancing immunotherapy by remodeling microenvironment, offering potential increase ICIs. this review summarizes associated mechanisms phytochemicals cancer. Additionally, focus on synergistic combining ICIs, aiming anticancer reduce effects, which may hopefully offer novel overcome current

Язык: Английский

Процитировано

0